RVM
GSK icon

Robinson Value Management’s GSK GSK Stock Holding History

Robinson Value Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.98M Sell
53,990
-2,178
-4% -$118K 1.66% 26
2025
Q4 		$2.75M Sell
56,168
-369
-0.7% -$17.2K 1.49% 27
2025
Q3 		$2.44M Sell
56,537
-232
-0.4% -$9.06K 1.42% 29
2025
Q2 		$2.18M Sell
56,769
-272
-0.5% -$10.4K 1.37% 30
2025
Q1 		$2.21M Sell
57,041
-60
-0.1% -$2.2K 1.43% 32
2024
Q4 		$1.93M Buy
57,101
+1,494
+3% +$53.8K 1.28% 35
2024
Q3 		$2.27M Sell
55,607
-60,849
-52% -$2.49M 1.48% 30
2024
Q2 		$4.48M Sell
116,456
-2,414
-2% -$102K 3.12% 7
2024
Q1 		$5.1M Sell
118,870
-9,209
-7% -$380K 3.42% 6
2023
Q4 		$4.75M Sell
128,079
-37
-0% -$1.33K 3.12% 7
2023
Q3 		$4.64M Sell
128,116
-3,561
-3% -$126K 3.46% 5
2023
Q2 		$4.69M Buy
131,677
+2,738
+2% +$98.2K 3.4% 4
2023
Q1 		$4.59M Sell
128,939
-3,179
-2% -$111K 3.52% 4
2022
Q4 		$4.64M Buy
132,118
+1,142
+0.9% +$38K 4% 3
2022
Q3 		$3.85M Buy
130,976
+54,838
+72% +$2.08M 3.84% 4
2022
Q2 		$4.14M Sell
76,138
-539
-0.7% -$29.8K 3.84% 5
2022
Q1 		$4.17M Sell
76,677
-1,465
-2% -$79.6K 3.24% 7
2021
Q4 		$4.31M Buy
78,142
+550
+0.7% +$28.6K 3.54% 7
2021
Q3 		$3.71M Buy
77,592
+39,877
+106% +$2M 3.31% 7
2021
Q2 		$1.88M Sell
37,715
-125
-0.3% -$6.01K 1.53% 29
2021
Q1 		$1.69M Sell
37,840
-1,880
-5% -$85.3K 1.39% 31
2020
Q4 		$1.83M Buy
+39,720
New +$1.82M 1.74% 28

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Robinson Value Management's GSK Position: Q1 2026 in Review

Robinson Value Management reduced its GSK (GSK) stake by 3.9% in Q1 2026, selling an estimated $118K and leaving 53,990 shares worth $2.98M. The position accounts for 1.66% of the portfolio, ranked #26.

Robinson Value Management first reported a position in GSK in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.1M in Q1 2024. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Robinson Value Management held 53,990 shares of GSK worth $2.98M as of Q1 2026.
  • Robinson Value Management sold 2,178 GSK shares in Q1 2026, an estimated $118K.
  • GSK made up 1.66% of Robinson Value Management's portfolio in Q1 2026, its #26 holding.
  • Robinson Value Management first reported a position in GSK in Q4 2020 and has held it in 22 quarters since.
  • Robinson Value Management's GSK position peaked at $5.1M in Q1 2024.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Robinson Value Management's 13F filing for Q1 2026, filed 5 May 2026.